Results 291 to 300 of about 107,800 (308)

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

Ca-A Cancer Journal for Clinicians, 2018
David A Mahvi, Rong Liu, Yolonda L Colson   +2 more
exaly  

Novel insights into mesothelioma biology and implications for therapy

Nature Reviews Cancer, 2017
Sanjay Popat, Dean A Fennell
exaly  

Deep learning-based classification of mesothelioma improves prediction of patient outcome

Nature Medicine, 2019
Mikhail Zaslavskiy, Nolwenn Le Stang
exaly  

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

Nature Genetics, 2016
Raphael Bueno, Leonard D Goldstein, Steffen Durinck   +2 more
exaly  

Germline BAP1 mutations predispose to malignant mesothelioma

Nature Genetics, 2011
Joseph R Testa, Jennifer E. Below, Yinfei Tan   +2 more
exaly  

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Nature Genetics, 2011
Matthew Bott, Marie Brevet, Lu Wang
exaly  

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Lancet, The, 2016
Gérard Zalcman, Julien Mazieres, Laurent Greillier   +2 more
exaly  

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

Journal of Clinical Oncology, 2003
Salih Emri
exaly  

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Hedy L Kindler, Nofisat Ismaila, Raphael Bueno   +2 more
exaly  

Mesothelioma in Childhood

Pediatric Hematology and Oncology, 1994
openaire   +3 more sources